Western Blot Detection of Protein Expression (siRNA Knock-Down Control)

TK Thomas Klag
MT Maria Thomas
DE Dirk Ehmann
LC Lioba Courth
DM Daniela Mailänder-Sanchez
TW Thomas S. Weiss
RD Rania Dayoub
KA Kerstin Abshagen
BV Brigitte Vollmar
WT Wolfgang E. Thasler
ES Eduard F. Stange
CB Christoph P. Berg
NM Nisar P. Malek
UZ Ulrich M. Zanger
JW Jan Wehkamp
request Request a Protocol
ask Ask a question
Favorite

For CAR knock-down validation we provide the mRNA expression levels of CYP2B6 as a target gene of CAR. PPARα and FXR protein expression levels following siRNA treatment in HepaRG cells were assessed by Western blot (see Figure S4 in Supplementary Material). Antibodies used: rabbit anti-human PPARα, (CAYMAN No. 101710, dilution 1:500), FXR (Abnova H00009971-M01, dilution 1:1,000), mouse anti-β-Actin (Sigma-Aldrich, A5441, 1:500), goat-anti-rabbit-IRD800 (Li-COR, 926-32214, 1:10,000), and goat-anti-mouse-IRD650 (Li-COR, 926-68074, 1:10,000) were used as fluorescently labeled secondary antibodies.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A